The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Mesoporous silica nanoparticles in target drug delivery system: A review
Open accessAbstract
Due to lack of specification and solubility of drug molecules, patients have to take high doses of the drug to achieve the desired therapeutic effects for the treatment of diseases. To solve these problems, there are various drug carriers present in the pharmaceuticals, which can used to deliver therapeutic agents to the target site in the body. Mesoporous silica materials become known as a promising candidate that can overcome above problems and produce effects in a controllable and sustainable manner. In particular, mesoporous silica nanoparticles (MSNs) are widely used as a delivery reagent because silica possesses favorable chemical properties, thermal stability, and biocompatibility. The unique mesoporous structure of silica facilitates effective loading of drugs and their subsequent controlled release of the target site. The properties of mesoporous, including pore size, high drug loading, and porosity as well as the surface properties, can be altered depending on additives used to prepare MSNs. Active surface enables functionalization to changed surface properties and link therapeutic molecules. They are used as widely in the field of diagnosis, target drug delivery, bio-sensing, cellular uptake, etc., in the bio-medical field. This review aims to present the state of knowledge of silica containing mesoporous nanoparticles and specific application in various biomedical fields.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,929
Mesoporous silica nanoparticles for drug delivery and biosensing applications
Slowing, I. I., Trewyn, B. G., Giri, S., & Lin, V. S. ‐. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200601191 · Cited by 1,699
Lai, C.-Y., Trewyn, B. G., Jeftinija, D. M., Jeftinija, K., Xu, S., Jeftinija, S., & Lin, V. S.-Y. (2003) · Journal of the American Chemical Society · doi:10.1021/ja028650l · Cited by 1,678
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Trewyn, B. G., Slowing, I. I., Giri, S., Chen, H.-T., & Lin, V. S.-Y. (2007) · Accounts of Chemical Research · doi:10.1021/ar600032u · Cited by 1,123
Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.201000538 · Cited by 1,074
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility
Tarn, D., Ashley, C. E., Xue, M., Carnes, E. C., Zink, J. I., & Brinker, C. J. (2013) · Accounts of Chemical Research · doi:10.1021/ar3000986 · Cited by 949
Huang, X., Li, L., Liu, T., Hao, N., Liu, H., Chen, D., & Tang, F. (2011) · ACS Nano · doi:10.1021/nn200365a · Cited by 921
A New Era for Cancer Treatment: Gold‐Nanoparticle‐Mediated Thermal Therapies
Kennedy, L. C., Bickford, L. R., Lewinski, N. A., Coughlin, A. J., Hu, Y., Day, E. S., West, J. L., & Drezek, R. A. (2011) · Small · doi:10.1002/smll.201000134 · Cited by 885
Surface Modification of Silica Nanoparticles to Reduce Aggregation and Nonspecific Binding
Bagwe, R. P., Hilliard, L. R., & Tan, W. (2006) · Langmuir · doi:10.1021/la052797j · Cited by 870
Cooperative Organization of Inorganic-Surfactant and Biomimetic Assemblies
Firouzi, A., Kumar, D., Bull, L. M., Besier, T., Sieger, P., Huo, Q., Walker, S. A., Zasadzinski, J. A., Glinka, C., Nicol, J., et al. (1995) · Science · doi:10.1126/science.7855591 · Cited by 777
Ordered mesoporous materials for drug delivery
Wang, S. (2009) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2008.07.002 · Cited by 678
Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity
Yu, T., Malugin, A., & Ghandehari, H. (2011) · ACS Nano · doi:10.1021/nn2013904 · Cited by 666
He, Q., Zhang, Z., Gao, F., Li, Y., & Shi, J. (2011) · Small · doi:10.1002/smll.201001459 · Cited by 661
The biocompatibility of mesoporous silicates
Hudson, S. P., Padera, R. F., Langer, R., & Kohane, D. S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.007 · Cited by 538
Brannon-Peppas, L. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00324-x · Cited by 528
Zhang, J., Yuan, Z.-F., Wang, Y., Chen, W.-H., Luo, G.-F., Cheng, S.-X., Zhuo, R.-X., & Zhang, X.-Z. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312004m · Cited by 517
Selvam, P., Bhatia, S. K., & Sonwane, C. G. (2001) · Industrial & Engineering Chemistry Research · doi:10.1021/ie0010666 · Cited by 497
Confinement and Controlled Release of Bisphosphonates on Ordered Mesoporous Silica-Based Materials
Balas, F., Manzano, M., Horcajada, P., & Vallet-Regí, M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062286z · Cited by 437
Enzymes supported on ordered mesoporous solids: a special case of an inorganic–organic hybrid
Yiu, H. H. P., & Wright, P. A. (2005) · Journal of Materials Chemistry · doi:10.1039/b506090g · Cited by 406
Silica-based nanoprobes for biomedical imaging and theranostic applications
Vivero-Escoto, J. L., Huxford-Phillips, R. C., & Lin, W. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15229k · Cited by 381
Silica-based mesoporous nanoparticles for controlled drug delivery
Kwon, S., Singh, R. K., Perez, R. A., Abou Neel, E. A., Kim, H.-W., & Chrzanowski, W. (2013) · Journal of Tissue Engineering · doi:10.1177/2041731413503357 · Cited by 370
Multifunctional Mesoporous Silica Nanoparticles for Cancer‐Targeted and Controlled Drug Delivery
Zhang, Q., Liu, F., Nguyen, K. T., Ma, X., Wang, X., Xing, B., & Zhao, Y. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201201316 · Cited by 324
Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles
Souris, J. S., Lee, C.-H., Cheng, S.-H., Chen, C.-T., Yang, C.-S., Ho, J.-A. A., Mou, C.-Y., & Lo, L.-W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.048 · Cited by 320
Fruijtier-Pölloth, C. (2012) · Toxicology · doi:10.1016/j.tox.2012.02.001 · Cited by 312
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet-Regí, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 270
Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging
Lin, X., Xie, J., Niu, G., Zhang, F., Gao, H., Yang, M., Quan, Q., Aronova, M. A., Zhang, G., Lee, S., et al. (2011) · Nano Letters · doi:10.1021/nl104141g · Cited by 264
Nanodrug delivery in reversing multidrug resistance in cancer cells
Yergeri, M., Kapse-Mistry, S., Srivastava, R., & Govender, T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00159 · Cited by 255
Wang, L.-S., Wu, L.-C., Lu, S.-Y., Chang, L.-L., Teng, I.-T., Yang, C.-M., & Ho, J.-A. A. (2010) · ACS Nano · doi:10.1021/nn901376h · Cited by 248
Lu, J., Li, Z., Zink, J. I., & Tamanoi, F. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.002 · Cited by 224
Mamaeva, V., Rosenholm, J. M., Bate-Eya, L. T., Bergman, L., Peuhu, E., Duchanoy, A., Fortelius, L. E., Landor, S., Toivola, D. M., Lindén, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.105 · Cited by 220
Gary-Bobo, M., Hocine, O., Brevet, D., Maynadier, M., Raehm, L., Richeter, S., Charasson, V., Loock, B., Morère, A., Maillard, P., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.11.045 · Cited by 186
Vallet-Regí, M., Izquierdo-Barba, I., & Colilla, M. (2012) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2011.0258 · Cited by 178
Integrated Hollow Mesoporous Silica Nanoparticles for Target Drug/siRNA Co‐Delivery
Ma, X., Zhao, Y., Ng, K. W., & Zhao, Y. (2013) · Chemistry – A European Journal · doi:10.1002/chem.201302736 · Cited by 176
Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy
Wu, X., Wu, M., & Zhao, J. X. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.08.008 · Cited by 168
Nanostructured porous Si-based nanoparticles for targeted drug delivery
Shahbazi, M., Herranz‐Blanco, B., & Santos, H. A. (2012) · Biomatter · doi:10.4161/biom.22347 · Cited by 144
Immobilization of bacteriophages on modified silica particles
Cademartiri, R., Anany, H., Gross, I., Bhayani, R., Griffiths, M. W., & Brook, M. A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.029 · Cited by 117
Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery
Klichko, Y., Liong, M., Choi, E., Angelos, S., Nel, A. E., Stoddart, J. F., Tamanoi, F., & Zink, J. I. (2009) · Journal of the American Ceramic Society · doi:10.1111/j.1551-2916.2008.02722.x · Cited by 116 · cited 1×
“[7] Various pore geometric structures were shown in Figure 1.”
Nanoparticles for Targeted and Temporally Controlled Drug Delivery
Swami, A., Shi, J., Gadde, S., Votruba, A. R., Kolishetti, N., & Farokhzad, O. C. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_2 · Cited by 108
Kim, S., Lee, Kim, Lee, Kwon, T. K., Yun, H., & Khang, D. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39534 · Cited by 97
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles
Fan, J., Fang, G., Wang, X., et al. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/45/455102 · Cited by 92
Effects of temperature on formation of silica gel
Colby, M. W., Osaka, A., & Mackenzie, J. D. (1986) · Journal of Non-Crystalline Solids · doi:10.1016/0022-3093(86)90108-0 · Cited by 89
Shchipunov, Y. A., Karpenko, T. Y., & Krekoten, A. V. (2005) · Composite Interfaces · doi:10.1163/1568554053148816 · Cited by 81
Luminescent Silica Nanoparticles for Cancer Diagnosis
Arap, W., Pasqualini, R., Montalti, M., Petrizza, L., Prodi, L., Rampazzo, E., Zaccheroni, N., & Marchiò, S. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320170005 · Cited by 77
Development of Mesoporous Silica Nanomaterials As a Vehicle for Anticancer Drug Delivery
Yanes, R. E., & Tamanoi, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.9 · Cited by 68
Formulation Design Facilitates Magnetic Nanoparticle Delivery to Diseased Cells and Tissues
Singh, D., McMillan, J., Liu, X.-M., Vishwasrao, H. M., Kabanov, A. V., Sokolsky‐Papkov, M., & Gendelman, H. E. (2014) · Nanomedicine · doi:10.2217/nnm.14.4 · Cited by 65
Functionalization of Mesoporous Silicon Nanoparticles for Targeting and Bioimaging Purposes
Rytkönen, J., Miettinen, R. A., Kaasalainen, M. H., Lehto, V., Salonen, J., & Närvänen, A. T. O. (2012) · Journal of Nanomaterials · doi:10.1155/2012/896562 · Cited by 65
Gelling of otherwise nongelable polysaccharides
Shchipunov, Y. A., Karpenko, T. Y., Krekoten, A. V., & Postnova, I. V. (2005) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2005.02.004 · Cited by 56
Packaging biological cargoes in mesoporous materials: opportunities for drug delivery
Siefker, J., Karande, P., & Coppens, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.938636 · Cited by 52
Tourné‐Péteilh, C., Bégu, S., Lerner, D. A., Galarneau, A., Lafont, U., & Devoisselle, J. (2011) · Journal of Sol-Gel Science and Technology · doi:10.1007/s10971-011-2646-x · Cited by 49
Phosphorus-containing SBA-15 materials as bisphosphonate carriers for osteoporosis treatment
Colilla, M., Izquierdo‐Barba, I., & Vallet‐Regí, M. (2010) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2010.06.010 · Cited by 40
Entrapment of Biopolymers into Sol—Gel‐derived Silica Nanocomposites
Shchipunov, Y. A. (2007) · Wiley eBooks · doi:10.1002/9783527621446.ch3 · Cited by 26
Trewyn, B. G., Slowing, I. I., Giri, S., Chen, H., & Lin, V. S. ‐. (2007) · ChemInform · doi:10.1002/chin.200750256 · Cited by 25
Bergman, L., Kankaanpää, P., Tiitta, S., Duchanoy, A., Li, L., Heino, J., & Lindén, M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005879 · Cited by 24
Functionalized mesoporous silica nanoparticles for stimuli-responsive and targeted
Knežević, N. Ž., & USDOE (2009) · doi:10.2172/1342579 · Cited by 2
Cited by
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Nanopharmaceuticals and Nanomedicines Currently on the Market: Challenges and Opportunities
Farjadian, F., Ghasemi, A., Gohari, O., Roointan, A., Karimi, M., & Hamblin, M. R. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0120 · Cited by 664
Nanotechnologies in Food Science: Applications, Recent Trends, and Future Perspectives
Nile, S. H., Baskar, V., Selvaraj, D., Nile, A., Xiao, J., & Kai, G. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-0383-9 · Cited by 631
Mesoporous silica nanoparticles for therapeutic/diagnostic applications
Jafari, S., Derakhshankhah, H., Alaei, L., Fattahi, A., Varnamkhasti, B. S., & Saboury, A. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.167 · Cited by 566
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
Metadata
- Authors
- Bharti, C., Gulati, N., Nagaich, U., & Pal, A.
- Venue
- International Journal of Pharmaceutical Investigation
- Publisher
- Manuscript Technomedia LLP
- Published
- 2015
- Volume
- 5
- Issue
- 3
- Pages
- 124
- ISSN
- 2230-9713 (ISSN-L)
- 2230-973X
- OpenAlex
- W1908453662
- Cited by
- 817
- References
- 61
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.